# Toward Immune Biomarkers for Tolerance and GvHD in Humans

> **NCT02319226** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 60 (actual)

## Conditions studied

- Bone Marrow Transplantation
- Graft vs Host Disease
- Hematopoietic Stem Cell Transplantation

## Interventions

- **OTHER:** Transplantation from an HLA-identical sibling donor

## Key facts

- **NCT ID:** NCT02319226
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2019-02
- **Final completion:** 2020-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02319226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02319226, "Toward Immune Biomarkers for Tolerance and GvHD in Humans". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02319226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*